Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years

Size: px
Start display at page:

Download "Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years"

Transcription

1 Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti, MS, and Terrence M. Yau, MD, MS Division of Cardiovascular Surgery, Peter Munk Cardiac Center, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada Background. Postoperative low cardiac output syndrome (LCOS) is associated with high morbidity and mortality after coronary artery bypass grafting (CABG). We sought to examine trends in predictors of LCOS after isolated CABG. Methods. A total of 25,176 consecutive patients who underwent isolated CABG between 1990 and 2009 were included. To examine trends over time, we divided patients into four equivalent eras (1990 to -1994, n 6,489; 1995 to 1999, n 8,175; 2000 to 2004, n 6,741; 2005 to 2009, n 3,797). We used multivariable analysis to identify predictors of LCOS. Results. The prevalence of LCOS declined from 9.1% (1990 to 1994) to 2.4% (2005 to 2009, p < 0.001). The following were the major independent predictors of LCOS for the entire cohort (odds ratios in parentheses): reoperative CABG (4.1); earlier year of operation (4.1, 2.6, 1.7 for the first, second, and third eras, respectively); left ventricular ejection fraction (LVEF) less than 0.20 (3.5), emergency surgery (2.7), cardiogenic shock (2.3), female gender (2), and LVEF 0.20 to 0.39 (2). Unlike other risk factors, the impact of LVEF less than 0.20 on development of postoperative LCOS increased substantially in the latest era (odds ratio, 7.8) compared with (odds ratios, 3.1, 4.3, and 3.2) the first, second, and third eras, respectively. Conclusions. The impact of LVEF less than 0.20 on development of postoperative LCOS has increased markedly in the latest era of our study. Prudent preoperative evaluation in patients with severe left ventricular dysfunction is critical. Further innovative research in myocardial protection and circulatory support is warranted in patients with severe left ventricular dysfunction. (Ann Thorac Surg 2011;92: ) 2011 by The Society of Thoracic Surgeons The development of low cardiac output syndrome (LCOS) after coronary artery bypass grafting (CABG) surgery is associated with a 10-fold to 17-fold increase in mortality and markedly increased morbidity [1].The reported prevalence of LCOS after isolated CABG is 3% to 14% [1 3]. The prevalence and the independent predictors of LCOS were described previously by Rao and associates [1]. However, no studies have examined temporal changes in predictors of LCOS in patients undergoing isolated CABG surgery. The purpose of this study was to examine trends over time in the prevalence of LCOS in patients undergoing CABG surgery over a 20-year period, as well as to identify changes in the independent predictors of LCOS with time. These findings may assist in identification of patients at high risk of postoperative LCOS and therefore facilitate preoperative planning and patient counselling, and guide potential preoperative interventions for optimization of high-risk subgroups. Accepted for publication June 8, Address correspondence to Dr Yau, Division of Cardiovascular Surgery, Toronto General Hospital, 4N-470, 200 Elizabeth St, Toronto, Ontario, Canada, M5G 2C4; terry.yau@uhn.on.ca. Patients and Methods Data Collection and Study Outcomes Clinical, operative, and outcome data were collected prospectively in a computerized database for 25,176 consecutive patients undergoing isolated CABG at our institution between January 1, 1990 and December 31, Patients undergoing CABG with concomitant procedures were excluded. To evaluate changing patterns of risk factors and outcomes over time, the study population (n 25,202) was divided into 4 eras (1990 to 1994, n 6,489; 1995 to 1999, n 8,175; 2000 to 2004, n 6,741, and 2005 to 2009, n 3,797). The study was approved by our Institutional Research Ethics board; individual patient consent was waived. Our primary outcome was LCOS, which was diagnosed if the patient required an intraaortic balloon pump (IABP) in the operating room to be weaned from cardiopulmonary bypass or in the intensive care unit because of hemodynamic compromise. The LCOS was also diagnosed if the patient required inotropic medication (either dopamine, dobutamine, milrinone, or epinephrine) to maintain a systolic blood pressure greater than 90 mm Hg and cardiac output greater than 2.2L min 1 m 2 for at least 30 minutes in the intensive care unit, after optimizing preload, and afterload as well as correcting all 2011 by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc doi: /j.athoracsur

2 Ann Thorac Surg ALGARNI ET AL 2011;92: LOW OUTPUT SYNDROME AFTER CORONARY BYPASS Table 1. Demographics and Clinical Profile Variable p Value No. of patients 6,489 8,175 6,741 3,797 Age (years) mean SD Less than Female Diabetes mellitus Hypertension Hyperlipidemia Angina Stable Crescendo ACS Preoperative MI Cardiogenic shock Congestive heart failure Preoperative IABP LVEF Left main disease Triple-vessel disease Preoperative stroke PVD Reoperative CABG Previous PCI stents Urgency of surgery Elective Semiurgent Urgent Emergency ADULT CARDIAC ACS acute coronary syndrome; CABG coronary artery bypass grafting; IABP intraaortic balloon pump; LVEF left ventricular ejection fraction; MI myocardial infarction; PCI percutaneous coronary intervention; PVD peripheral vascular disease. electrolyte and blood gas abnormalities. Patients who required a renal dose of dopamine ( 4 g/kg) or those who received vasoconstricting medications to increase peripheral vascular resistance in the presence of normal or high cardiac output ( 2.5 L min 1 m 2 ) were not considered to have LCOS. Statistical Analysis Statistical analysis was performed with SAS 9.2 software (SAS Institute, Inc, Cary, NC). We used the 2 or Fisher exact test to analyze categoric data. Categoric variables were expressed as percentages. Analysis of variance was used to analyze continuous variables that are normally distributed, and the Kruskal-Wallis test was used for variables with a nonparametric distribution. Continuous variables were expressed as means standard deviations. Statistical significance was based on two-sided p values less than Variables that had a univariate p value of less than 0.25 and those of biological importance were selected for inclusion in a multivariable logistic regression model. Multivariable analysis was performed for the entire cohort of 25,176 patients as well as for each era separately to determine the independent predictors of LCOS for the entire cohort and for each era separately. Model discrimination and calibration were evaluated by the area under the receiver operating characteristic curve, and the Hosmer Lemeshow goodness-of-fit statistic, respectively. Results Demographics and Baseline Clinical Profile Preoperative patient characteristics are detailed in Table 1. The prevalence of most risk factors increased steadily with time. About 20% of patients were 75 years and older

3 1680 ALGARNI ET AL Ann Thorac Surg LOW OUTPUT SYNDROME AFTER CORONARY BYPASS 2011;92: Table 2. Operative Data and Postoperative Outcomes Variable p Value Intraoperative variables LITA use RITA use Radial artery use a No. of grafts CPB time (minutes) Cross-clamping time (minutes) Cardioplegia technique Intermittent cold antegrade Warm or tepid cardioplegia Off pump Postoperative outcomes Mortality Inotrope use 30 minutes Low-output syndrome IABP Myocardial infarction Stroke Renal failure Pulmonary complications Sternal wound infection Superficial Deep Sepsis Duration of ventilation (hours) Intensive care unit stay (hours) Hospital stay (days) a Radial artery data was not collected during the first time cohort ( ). CPB cardiopulmonary bypass; IABP intraaortic balloon pump; LITA left internal thoracic artery; RITA right internal thoracic artery. in the latest time cohort versus 7.5% of patients in the first one. The prevalence of left main disease doubled between the first and the last time cohort (18.2% vs 34.9%). In contrast, the prevalence of left ventricular dysfunction and reoperative CABG has declined significantly with time. Operative and Hospital Outcomes Operative profiles and postoperative outcomes are detailed in Table 2. The overall prevalence of LCOS for the entire cohort was 5.7% (n 1,431). The prevalence of LCOS declined from 9.1% (n 588) in the first time cohort to 2.4% (n 91) in the last one (p ). In-hospital mortality declined from 2.5% in the first era to 1.4% in the last one (p ). The prevalence of most postoperative complications declined significantly with time. However, there was a trend of increasing prevalence of sepsis with time. The duration of ventilation and intensive care unit stay has fluctuated with time. Nonetheless, the length of hospital stay decreased significantly with time. Postoperative Outcomes Stratified by LCOS Table 3 details the postoperative outcomes in patients who developed LCOS compared with those who did not. Across the four eras, operative mortality was higher in patients with LCOS (17.7% vs 0.9%, 18.5% vs 0.6%, 12.8 vs 0.6%, and 24% vs 0.8%), respectively (p ). Similarly, patients with LCOS had significantly longer ventilatory support, intensive care unit stay, hospital stay, and more blood transfusion. Moreover, the risk of mortality in patients with LCOS increased significantly in the latest era, where 22 out of 91 patients with LCOS died in the latest era (24%) compared with mortality of 17.7%, 18.5%, and 12.8% for the LCOS group in the first, second, and third eras, respectively. Thus LCOS was associated with a 29-fold increase in mortality in the latest era, compared with a 17-fold increase in the first era of this study. Predictors of LCOS Predictors of LCOS are detailed in Table 4. Reoperative CABG (odds ratio [OR], 4.1) and the first era of surgery (OR, 4.1) carried the highest odds of LCOS, followed by LVEF less than 0.20 (OR, 3.5) and then emergency CABG (OR, 2.7). Table 5 presents the odds ratios for independent predictors of LCOS across the four eras of the study. The predictors of LCOS have changed significantly with time. In the latest era, only four variables emerged as significant predictors of LCOS; LVEF less than 0.20 (OR, 7.8),

4 Ann Thorac Surg ALGARNI ET AL 2011;92: LOW OUTPUT SYNDROME AFTER CORONARY BYPASS Table 3. Outcomes Stratified by Low Cardiac Output Syndrome Status a Variable Mortality LCOS % (n) 17.7 (588) 18.5 (487) 12.8 (265) 24.2 (91) No LCOS % (n) 95 (5,892) 61 (7,677) 56 (6,471) 84 (3,705) Intensive care unit stay (hours) LCOS No LCOS Duration of ventilation (hours) LCOS No LCOS Postoperative hospital stay (days) LCOS No LCOS ADULT CARDIAC a p for each individual grouping variable and across the four eras. LCOS low cardiac output syndrome. reoperative CABG (OR, 5.4), LVEF 0.20 to 0.39 (OR, 4), and emergent-urgent surgery (OR, 2.5). Figure 1 shows that the observed frequency of LCOS declined with time in all high-risk categories except patients with LVEF less than In these patients with severe LV dysfunction, the prevalence of LCOS increased from 10.7% in the third era of this study to 18.2% in the latest era. LVEF Less Than 0.20 Unlike other predictive variables, the prevalence of LCOS increased significantly in patients with LVEF less than 0.20 in the most recent era (18.2%) compared with the third era of this study (10.7%). We used a Cochrane Mantel-Haenszel test to compare the odds of developing LCOS in patients with LVEF less than 0.20 across the four eras. The odds ratio for LCOS in patients with LVEF less Table 4. Multivariable Predictors of Low Cardiac Output Syndrome (n 25,176) Variable n Estimate SE Odds Ratio 95% CI p Value Constant Age a Female gender 5, Diabetes 7, Cardiogenic shock Congestive heart failure 2, Peripheral vascular disease 4, Reoperative CABG 1, Left main disease 5, LVEF b , , Urgency of surgery Same hospitalization Urgent 2, Emergent Year of operation c 6, c 8, c 6, a Age is a continuous variable. b Odds ratios were calculated by comparing against LVEF 60%. c Odds ratios were calculated by comparing against the 2005 to 2009 time cohort. The area under the receiver operating characteristic curve was The Hosmer Lemeshow goodness-of-fit p value was CABG coronary artery bypass grafting surgery; CI confidence interval; LVEF left ventricular ejection fraction; SE standard error.

5 1682 ALGARNI ET AL Ann Thorac Surg LOW OUTPUT SYNDROME AFTER CORONARY BYPASS 2011;92: Table 5. Trends in Odds Ratios for Predictors of Low Cardiac Output Syndrome Variable a b c d LVEF LVEF Reoperative CABG Emergency/ urgent surgery Female sex Hypertension Age Left main disease Triple vessels disease Diabetes 1.5 a C-statistic is 0.75, the Hosmer-Lemeshow goodness-of-fit p value was 0.1. b C-statistic is 0.77, the Hosmer-Lemeshow goodness-of-fit p value is c C-statistic is 0.76, the Hosmer-Lemeshow goodnessof-fit p value is d C-statistic is The Hosmer-Lemeshow goodness-of-fit p value is The numbers in the last four columns represents odds ratios. CABG coronary artery bypass grafting surgery; LVEF left ventricular ejection fraction. than 0.20 compared with those with LVEF 0.20 or less was 3.7 (CI, 2.7 to 5.2), 5.2 (CI, 3.8 to 7.1), 3.1 (CI, 1.9 to 5.1), and 9.8 (CI, 4.4 to 21.7) in the first, second, third, and fourth eras, respectively (p 0.04). This indicates that the odds of developing LCOS in patients with LVEF less than 0.20 increased by a relative 80% to 200% in the latest era (OR, 9.8) compared with the previous three eras. This difference was statistically significant by univariate analysis (p 0.04). Furthermore, multivariable analysis (Table 5) confirms this finding, where the OR increased to 7.8 in the most recent era compared with an OR of 3.1, 4.3, and 3.2 in the first three eras, respectively. Figure 2 presents the risk profile of patients with LVEF less than 0.20 across the four eras of this study. The prevalence of elderly patients, preoperative myocardial infarction, left main disease, and congestive heart failure increased markedly in patients with LVEF less than 0.20 over the time span of this study. Comment In the present study, we examined the trends in prevalence and the changes in predictors of LCOS over time in a large series of patients who underwent isolated CABG surgery at our institution over 2 decades (1990 to 2009). The significance of most predictors of LCOS has declined over time, whereas the impact of severe LV dysfunction (LVEF 0.20) on the development of postoperative LCOS has increased significantly in the latest era of this study. The prevalence of LCOS has declined significantly with time; however, its associated morbidity and mortality has increased. Maganti and associates [5] found similar trends in patients undergoing isolated mitral valve surgery, where LCOS-associated mortality increased from 23% (23 of 100) in the earliest era of their study (1990 to 1995) to 35% (16 of 46) in the last era (2002 to 2008). In their study, LCOS was associated with a 30-fold increase in mortality [4]. Further, LCOS portended even a higher risk of mortality in patients undergoing isolated aortic valve surgery, a 38-fold increase in mortality [5]. This makes LCOS perhaps the most serious complication after cardiac surgery. Indeed, in a multicenter prospective study performed by the Northern New England Cardiovascular Disease Study Group, 384 deaths in 8,641 consecutive patients undergoing isolated CABG between 1990 and 1995 were analyzed with respect to the mode of death. Persistent low cardiac output was judged to be the primary mode of death in 65% of the patients [6]. We believe that the trend of increasing mortality with time in patients with LCOS is partially driven by the worsening risk profile of these patients with time. Indeed, about 20% of patients with LCOS were 75 years or older in the latest era compared with 11.5% in the first one (p 0.008). Similarly, the prevalence of preoperative Fig 1. Prevalence of low cardiac output syndrome by high-risk factors. Left ventricular ejection fraction (LVEF) less than 0.20, reoperative coronary artery bypass grafting surgery (redo CABG), emergent and urgent surgery (Emerg/urg), elderly patients 75 years and older (Age 75 ), left main coronary stenosis (Left main), and female gender.

6 Ann Thorac Surg ALGARNI ET AL 2011;92: LOW OUTPUT SYNDROME AFTER CORONARY BYPASS 1683 Fig 2. Risk profile of patients with left ventricular ejection fraction less than 0.20 by era of surgery. (CHF congestive heart failure; LMD left main coronary disease; Preop MI preoperative myocardial infarction; Preop shock preoperative cardiogenic shock. Numbers over the bars are the p values.) ADULT CARDIAC myocardial infarction (39% vs 28%, p 0.02), left main disease (46.2% vs 23.6%, p 0.001), and requirement of preoperative IABP (20% vs 9.2, p 0.001) were all higher in patients with LCOS during the latest era of this study compared with the first one. Moreover, another potential driver of increasing mortality and morbidity in patients with LCOS in the latest era is the higher proportion of LCOS in patients with severe LV dysfunction, representing a very sick population of patients with multiple comorbidities and dismal LV function. LV Dysfunction Contrary to our initial assumptions, the prevalence of patients with moderate to severe LV dysfunction (LVEF 0.40) decreased steadily with time. We hypothesized that this decline might be related to a shift of patients with poor LV function from isolated CABG to combined CABG and valvular surgery, particularly mitral surgery. Exploratory analyses of our institutional data demonstrated an increase in the prevalence of LVEF less than 0.40 among patients who underwent combined mitral valve surgery (24.4%, 32.5%, 38.5%, and 39.1% for the first, second, third, and forth eras, respectively). This shift of patients with LVEF less than 0.40 from the isolated CABG group to the combined CABG and mitral valve surgery group over the last two decades appears to explain most of the reduced prevalence of moderate to severe LV systolic dysfunction in our isolated CABG patients. However, our data cannot clarify whether there was a simultaneous decrease in the referral of patients with left ventricular dysfunction for CABG in favor of percutaneous coronary intervention. Severe LV dysfunction (LVEF 0.20) was the most significant predictor of LCOS in the most recent era of this study. Several studies have shown that over time, the relative influence of left ventricular dysfunction on postoperative adverse outcomes has declined [7 10]. This was true during the first three eras of our study; however, the influence of severe LV dysfunction on development of LCOS has increased significantly in the most recent era of our study compared with the first three eras. There are several potential explanations for this trend. First, this trend can be explained partly by the worsening risk profile of patients with LVEF less than 0.20 over time. Also, surgeons might have had a lower threshold in the latest era to operate on patients with dismal LV function given advances in circulatory support. Additionally, it is possible that the degree of severity of LV dysfunction was higher in the latest era of this study, leading to the higher prevalence of LCOS in the latest era among patients with LVEF less than However, we can only speculate on this last explanation, as our data do not capture the exact LV ejection fraction. The increasing prevalence of LCOS in patients with LVEF less than 0.20 puts these patients at high risk of mortality and morbidity. Therefore, prudent preoperative planning is critical in this high-risk group. Preoperative prophylactic insertion of an IABP is justifiable in this high-risk group and may reduce the risk of morbidity and mortality [11]. Additionally, patients with LVEF less than 0.20 should be screened and evaluated preoperatively for potential requirement of circulatory support or consideration of heart transplantation. If a patient with LCOS fails to respond to IABP and inotropic support, implantation of ventricular assist devices as a bridge either to recovery or to transplantation has been shown to be beneficial, often resulting in successful discharge from the hospital [12 14]. Indeed, early implementation of mechanical circulatory assistance in the setting of postoperative LCOS to provide mechanical unloading of the ventricle and rapid restoration of normal end-organ perfusion is associated with improved survival rates [15 17]. The multivariable analysis showed that the impact of most risk factors on the development of LCOS has declined with time, which we believe is the result of refinements and advancements in perioperative surgical and anesthetic techniques. Importantly, cardioplegia techniques have evolved significantly in our institution over the span of this study. Diluted 4:1 blood-tocrystalloid cardioplegia was employed during the first era. Less diluted 8:1 blood cardioplegia was used in the

7 1684 ALGARNI ET AL Ann Thorac Surg LOW OUTPUT SYNDROME AFTER CORONARY BYPASS 2011;92: second and the third eras. In the latest era, undiluted 66:1 blood cardioplegia (microplegia) was used exclusively, and may have accounted in part for the reduction in the prevalence of LCOS and probably lessened the impact of several risk factors on the development of postoperative LCOS. Indeed, previous studies have shown that microplegia is associated with reduced myocardial edema due to a reduction in the volume of crystalloid delivered to the heart, and that this reduced edema may improve myocardial recovery after cardioplegic arrest [18 21]. Our study also has some limitations. Although the data were prospectively collected, this study remains a retrospective review of a single-center experience. Additionally, two decades of coronary surgery were included in this study, during which both perioperative and postoperative management for coronary disease have changed significantly. However, we tried to account for the time effect by dividing our cohort into four equivalent eras. In conclusion, the significance of most predictors of LCOS has declined over time. Importantly, the impact of severe LV dysfunction (LVEF 0.20) on the development of postoperative LCOS has increased significantly in the latest era of this study. Patients with severe LV dysfunction should be the focus of further research, especially in the areas of preoperative risk stratification, perioperative myocardial protection, and postoperative circulatory support. Terrence M. Yau holds the Angelo & Lorenza DeGasperis Chair in Cardiovascular Surgery Research at the University of Toronto. References 1. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996;112: Hogue CW Jr, Sundt T 3rd, Barzilai B, Schectman KB, Dávila-Román VG. Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. Anesthesiology 2001;95: Baillot RG, Joanisse DR, Stevens LM, Doyle DP, Dionne B, Lellouche F. Recent evolution in demographic and clinical characteristics and in-hospital morbidity in patients undergoing coronary surgery. Can J Surg 2009;52: Maganti M, Badiwala M, Sheikh A, et al. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg 2010;140: Maganti MD, Rao V, Borger MA, Ivanov J, David TE. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 2005;112: O Connor GT, Birkmeyer JD, Dacey LJ, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 1998;66: Topkara VK, Cheema FH, Kesavaramanujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005;112: Davierwala PM, Maganti M, Yau TM. Decreasing significance of left ventricular dysfunction and reoperative surgery in predicting coronary artery bypass grafting associated mortality: a twelve-year study. J Thorac Cardiovasc Surg 2003;126: Pasquet A, Lauer MS, Williams MJ, Secknus MA, Lytle B, Marwick TH. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction: Impact of preoperative myocardial function, perfusion and metabolism. Eur Heart J 2000; 21: Appoo J, Norris C, Merali S, et al. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation 2004;110: Santarpino G, Onorati F, Rubino AS, et al. Preoperative intraaortic balloon pumping improves outcomes for highrisk patients in routine coronary artery bypass graft surgery. Ann Thorac Surg 2009;87: Leshnower BG, Gleason TG, O Hara ML, et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg 2006; 81: Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg 2000;12: Pae WE Jr, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg 1992; 104: Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Results of mechanical ventricular assistance for the treatment of post cardiotomy cardiogenic shock. ASAIO J 1996; 42: DeRose JJ Jr, Umana JP, Argenziano M, et al. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices. Ann Thorac Surg 1997;64: Helman DN, Morales DL, Edwards NM, et al. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 1999;68: Menasché P. Blood cardioplegia: do we still need to dilute? Ann Thorac Surg 1996;62: Machiraju VR, Lima CA, Culig MH. The value of minicardioplegia in the clinical setting. Ann Thorac Surg 1997;64: McCann UG 2nd, Lutz CJ, Picone AL, et al. Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass. J Extra Corpor Technol 2006;38: Velez DA, Morris CD, Budde JM, et al. All-blood (Miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving iinfarction. Circulation 2001;104:I-296. INVITED COMMENTARY Algarni and colleagues [1] present a 20-year analysis of a large cohort of patients undergoing coronary artery bypass grafting, in which they document a decrease in the prevalence of low cardiac output syndrome, improved in-hospital mortality, and a reduction in major postoperative complications over this 20-year span. Two unexpected findings in the current era were an increase in mortality among patients suffering low cardiac output syndrome and an increase in the likelihood of low cardiac output syndrome among patients with an ejection frac by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc doi: /j.athoracsur

The results of aortic valve (AV) surgery continue to improve

The results of aortic valve (AV) surgery continue to improve Predictors of Low Cardiac Output Syndrome After Isolated Aortic Valve Surgery Manjula D. Maganti, MSc; Vivek Rao, MD, PhD; Michael A. Borger, MD, PhD; Joan Ivanov, PhD; Tirone E. David, MD Background Low

More information

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular

More information

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity? Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication

More information

Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery

Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,

More information

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,

More information

Ischemic Ventricular Septal Rupture

Ischemic Ventricular Septal Rupture Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor

More information

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87

More information

High-Risk Conventional Cardiac Surgery: Current Strategy. Disclosures: Edwards, Medtronic (Speaker)

High-Risk Conventional Cardiac Surgery: Current Strategy. Disclosures: Edwards, Medtronic (Speaker) High-Risk Conventional Cardiac Surgery: Current Strategy Disclosures: Edwards, Medtronic (Speaker) High-Risk Cardiac Surgery Considerations What defines high-risk? Strategies for preop optimization What

More information

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed

More information

AllinaHealthSystem 1

AllinaHealthSystem 1 : Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Percutaneous Mechanical Circulatory Support Devices

Percutaneous Mechanical Circulatory Support Devices Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute FINANCIAL DISCLOSURES none CASE STUDY CASE STUDY 52 year old gentlemen Complaining of dyspnea

More information

Extra Corporeal Life Support for Acute Heart failure

Extra Corporeal Life Support for Acute Heart failure Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical

More information

Copyright by ICR Publishers 2005

Copyright by ICR Publishers 2005 Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of

More information

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA

More information

Alex versus Xience Registry Preliminary report

Alex versus Xience Registry Preliminary report Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor

More information

Intra-operative Echocardiography: When to Go Back on Pump

Intra-operative Echocardiography: When to Go Back on Pump Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory

More information

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist

More information

In the United States, 97 million overweight or obese

In the United States, 97 million overweight or obese The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Yerebakan et al. Journal of Cardiothoracic Surgery 2014, 9:141

Yerebakan et al. Journal of Cardiothoracic Surgery 2014, 9:141 Yerebakan et al. Journal of Cardiothoracic Surgery 2014, 9:141 RESEARCH ARTICLE Open Access Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute

More information

British Journal of Anaesthesia 89 (3): 398^04 (2002)

British Journal of Anaesthesia 89 (3): 398^04 (2002) British Journal of Anaesthesia 89 (3): 398^04 (2002) Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia

More information

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Table S1: Proportion of missing values presents in the original dataset Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)

More information

Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement

Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

Ted Feldman, M.D., MSCAI FACC FESC

Ted Feldman, M.D., MSCAI FACC FESC Support Technologies and High Risk Intervention Patient Selection: When Not to Use Them Ted Feldman, M.D., MSCAI FACC FESC Evanston Hospital SCAI Fall Fellows Course Las Vegas December 7-10 th, 2014 Ted

More information

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Transfusion & Mortality. Philippe Van der Linden MD, PhD Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:

More information

IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION

IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION Michel Carrier, MD L. Conrad Pelletier, MD Raymond Martineau, MD Michel Pellerin, MD

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Divisions of Cardiology and Cardiovascular Surgery, Veterans Administration Medical Center and University of Minnesota, Minneapolis, Minnesota

Divisions of Cardiology and Cardiovascular Surgery, Veterans Administration Medical Center and University of Minnesota, Minneapolis, Minnesota Comparison of Risk Scores to Estimate Perioperative Mortality in Aortic Valve Replacement Surgery Jagroop Basraon, DO, Yellapragada S. Chandrashekhar, MD, Ranjit John, MD, Adheesh Agnihotri, MD, Rosemary

More information

Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk

Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk Original Article Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk Takashi Yamauchi, MD, PhD, 1 Takafumi Masai, MD, PhD, 1 Koji Takeda, MD, 1 Satoshi Kainuma,

More information

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik Håkanson, MD, PhD, and Rolf Svedjeholm, MD, PhD Departments

More information

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Modeling and Risk Prediction in the Current Era of Interventional Cardiology

Modeling and Risk Prediction in the Current Era of Interventional Cardiology Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Management of Acute Shock and Right Ventricular Failure

Management of Acute Shock and Right Ventricular Failure Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK

More information

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David

More information

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart

More information

Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database

Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce

More information

Coronary artery bypass graft (CABG) operations have

Coronary artery bypass graft (CABG) operations have Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care

More information

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques

More information

6 GERIATRIC CARDIAC SURGERY

6 GERIATRIC CARDIAC SURGERY 6 GERIATRIC CARDIAC SURGERY Nicola Francalancia, MD; Joseph LoCicero III, MD, FACS* Cardiovascular disease is the leading cause of death in the United States; 84% of deaths from cardiovascular disease

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Variability in Surgeons Perioperative Practices May Influence the Incidence of Low-Output Failure After Coronary Artery Bypass Grafting Surgery

Variability in Surgeons Perioperative Practices May Influence the Incidence of Low-Output Failure After Coronary Artery Bypass Grafting Surgery Variability in Surgeons Perioperative Practices May Influence the Incidence of Low-Output Failure After Coronary Artery Bypass Grafting Surgery Donald S. Likosky, PhD; Joshua B. Goldberg, MD; Anthony W.

More information

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of

More information

Management of Cardiogenic shock. Prof. Christian JM Vrints

Management of Cardiogenic shock. Prof. Christian JM Vrints Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease

More information

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018 Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac

More information

The Case for Multivessel Revascularization in Shock

The Case for Multivessel Revascularization in Shock The Case for Multivessel Revascularization in Shock Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute 9.37 9.49 am Disclosures Consulting/speaker honoraria: Abbott Vascular, American Heart Association

More information

Supplementary Online Content

Supplementary Online Content 1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;

More information

Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft

Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft M. Buerke, K. Krohe, M. Russ, C. Schneider, H. Lemm, R. Prondzinsky, I. Friedrich,

More information

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.

More information

Retrospective Study Of Redo Cardiac Surgery In A Single Centre. R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi, K Balakrishnan

Retrospective Study Of Redo Cardiac Surgery In A Single Centre. R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi, K Balakrishnan ISPUB.COM The Internet Journal of Anesthesiology Volume 12 Number 2 Retrospective Study Of Redo Cardiac Surgery In A Single Centre R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi,

More information

Myocardial enzyme release after standard coronary artery bypass grafting

Myocardial enzyme release after standard coronary artery bypass grafting Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,

More information

Deep Sternal Wound Infection: Risk Factors and Outcomes

Deep Sternal Wound Infection: Risk Factors and Outcomes Deep Sternal Wound Infection: Risk Factors and Outcomes Michael A. Borger, MD, Vivek Rao, MD, Richard D. Weisel, MD, Joan Ivanov, MSc, Gideon Cohen, MD, Hugh E. Scully, MD, and Tirone E. David, MD Division

More information

Coronary artery bypass grafting (CABG) is one of the most intensely scrutinized

Coronary artery bypass grafting (CABG) is one of the most intensely scrutinized Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie

More information

Low cardiac output syndrome (LCOS) is one of the most. Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Grafting

Low cardiac output syndrome (LCOS) is one of the most. Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Grafting Summary Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Grafting WenJun Ding, 1* MD, Qiang Ji, 2* MD, YunQing Shi, 1 MD, and RunHua Ma, 1 MD Low cardiac output syndrome

More information

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,

More information

ery: Comparison of Predicted and Observed Resu ts

ery: Comparison of Predicted and Observed Resu ts Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,

More information

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California High Risk PCI Making Possible the Impossible Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California Disclosures Abiomed Research Support Consulting Agreement

More information

Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations

Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations Review Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations Tohru Sakamoto, MD, PhD Left ventricular function on patients with

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models

The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,

More information

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director

More information

Intraoperative application of Cytosorb in cardiac surgery

Intraoperative application of Cytosorb in cardiac surgery Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Setting The setting was a hospital. The economic study was carried out in Australia.

Setting The setting was a hospital. The economic study was carried out in Australia. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,

More information

Intraoperative and Postoperative Risk Factors for Respiratory Failure After Coronary Bypass

Intraoperative and Postoperative Risk Factors for Respiratory Failure After Coronary Bypass Intraoperative and Postoperative Risk Factors for Respiratory After Coronary Bypass Charles C. Canver, MD, and Jyotirmay Chanda, MD, PhD Division of Cardiothoracic Surgery, The Heart Institute, Albany

More information

Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery

Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery University of Ottawa Heart Institute Jean Yves Dupuis, MD, FRCPC Cardiac Division of Anesthesiology Disclosure

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Mechanical Cardiac Support in Acute Heart Failure Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Disclosures Research Support and/or Consulting NHLBI Amgen Cytokinetics

More information

Final published version:

Final published version: Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database

More information

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis April 11, 2014 Jason O. Robertson, M.D., M.S.; David C. Naftel, Ph.D., Sunil

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

Cardiovascular Surgery. Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery

Cardiovascular Surgery. Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery Cardiovascular Surgery Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery Rajendra H. Mehta, MD, MS; Joshua D. Grab, MS; Sean M. O Brien, PhD; Charles

More information